Edwards Lifesciences Corporation to Present at the Canaccord Genuity Growth Conference

Published: Aug 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINE, CA--(Marketwired - August 12, 2013) -

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Canaccord Genuity Growth Conference 2013 on Wednesday, August 14, 2013. Thomas M. Abate, Edwards' corporate vice president and chief financial officer, is scheduled to speak to attendees at the InterContinental Boston at 2:30 p.m. EDT.

A live webcast will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following the presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.


Media Contact:
Sarah Huoh
949-250-5070

Investor Contact:
David K. Erickson
949-250-6826

Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
www.edwards.com



Help employers find you! Check out all the jobs and post your resume.

Back to news